Table 3.

Comparison of Full Blood Count Parameters and T‐Cell Subsets in Subgroups of Patients.

			PLT (*103/μL)		WBC (*103/μL)		Neutrophils (*103/μL)		Lymphocytes (*103/μL)		NLR		PLR		CD3 (*103/μL)		CD4 (*103/μL)		CD8 (*103/μL)		CD4/CD8		CD4/CD3		CD8/CD3
		N (%)	x˜	P	x˜	P	x˜	P	x˜	P	x˜	P	x˜	P	x˜	P	x˜	P	x˜	P	x˜	P	x˜	P	x˜	P
Age	<60	15 (23)	237	.04	7.30	.64	4.20	.99	1.60	.41	2.42	.27	238	.04	1.50	.23	0.83	.13	0.49	.79	1.89	.77	0.64	.99	0.34	.53
	≥60	50 (77)	206		7.31		4.80		1.65		2.94		208		1.26		0.71		0.45		1.64		0.63		0.38
Status	First treatment	52 (80)	217	.72	7.25	.82	4.65	.51	1.63	.74	2.86	.5	218	.71	1.34	.53	0.77	.18	0.42	.46	1.94	.03	0.66	.04	0.34	.03
	Recurrence	13 (20)	208		7.31		4.80		1.63		2.86		210		1.32		0.71		0.54		1.40		0.59		0.42
Site	GL	55 (85)	212	.46	7.31	.58	4.70	.14	1.66	.31	2.70	.046	214	.43	1.34	.66	0.74	.74	0.49	.61	1.67	.97	0.64	.84	0.38	.96
	SGL	10 (15)	242		7.13		5.79		1.22		3.83		244		0.97		0.65		0.35		1.80		0.62		0.35
T	T0‐T2	39 (60)	212	.7	7.20	.58	4.75	.9	1.66	1	2.98	.57	214	.68	1.32	.74	0.72	.51	0.45	.67	1.43	.17	0.59	.22	0.40	.19
	T3‐T4	26 (40)	220		7.65		4.80		1.58		2.36		222		1.34		0.73		0.47		2.00		0.67		0.33
N category	N0	59 (91)	212	.23	7.26	.02	4.70	.09	1.56	.07	2.86	.78	214	.22	1.32	.04	0.71	.01	0.46	.66	1.66	.25	0.61	.22	0.38	.32
	N+	6 (9)	241		9.14		5.50		2.20		2.92		243		1.76		1.15		0.42		2.44		0.69		0.29
Risk factors	No	44 (68)	217	.86	7.36	.98	4.73	.96	1.67	.98	3.00	.67	218	.88	1.32	.96	0.78	.78	0.47	.89	1.68	.73	0.65	.79	0.38	.62
	Yes	21 (32)	207		7.30		4.80		1.53		2.44		208		1.37		0.71		0.46		1.66		0.61		0.37

Median (x˜) values reported; P values by Mann–Whitney test.

NLR = neutrophil‐to‐lymphocyte ratio; PLR = platelet‐to‐lymphocyte ratio; PLT = platelets; Risk factors = perineural invasion and/or lymphovascular invasion; WBC = white blood cells.